Mindbio taps Chile policy "expert" for mining push

Executive Summary

• Mindbio Therapeutics Corp. has appointed Felipe Leyton, a prominent South American drug policy and mining safety expert, to lead the commercialization of its AI-driven voice-initiated drug and alcohol screening platform specifically within the South American mining sector.
• The appointment marks a strategic transition for Mindbio from advanced development to commercial field deployment, leveraging Leyton’s regulatory authority and industry access to accelerate enterprise adoption.
• The company is nearing completion of its integrated Edge AI hardware-software kiosk prototype, with on-site field testing at mining operations scheduled to commence in Q2 2026.

Key Details

• Appointment Details: Felipe Leyton appointed to lead commercialization across the South American mining sector.
• Candidate Background:
  • Former Head of Chile's National Alcohol Prevention Unit.
  • Led technical and operational implementation of Chile's "Zero Tolerance" alcohol-impaired driving framework.
  • Contributed to the design of Chile's national roadside drug testing program (launched 2019).
  • Currently a partner at TConsulting, advising major Chilean mining operators, government ministries, and international organizations on regulatory compliance and industrial safety.
• Strategic Mandate:
  • Develop and finalize mining-specific testing protocols with Mindbio's engineering team.
  • Expand clinical validation and refine AI prediction models.
  • Strengthen multisubstance detection capabilities (including cocaine, benzodiazepines, amphetamines, cannabis, hallucinogens, and alcohol).
  • Develop scalable enterprise licensing frameworks for mining operators.
  • Oversee phased deployment into active mining environments.
• Product Development Status:
  • Integrated Edge AI hardware-software kiosk system is near completion of prototype design.
  • Platform features rapid, non-invasive screening and real-time AI-driven impairment prediction using voice analysis.
  • On-site field testing at mining operations is scheduled to commence in Q2 2026.
• Market Opportunity Data (Chile):
  • Alcohol consumption among mining workers exceeds 75%.
  • Approximately 40% of workers are classified as problem drinkers.
  • Approximately 9% report drug use.
  • Mining workforce exceeds 200,000 individuals.
• Global Context: Estimated 20-25% of occupational accidents are linked to substance use.

Notable Quotes

• "Mr. Leyton brings exceptional credibility, regulatory authority and direct access to the mining industry. He helped design and implement Chile's Zero Tolerance alcohol framework at a national level, and he now leads the commercialization in a world-first AI voice-based impairment detection platform for mining." — Justin Hanka, CEO, Mindbio Therapeutics Corp.
• "This marks a transition from technology development to structured commercial deployment. We believe this positions Mindbio at the forefront of next-generation industrial safety solutions and voice-initiated health diagnostic technologies." — Justin Hanka, CEO, Mindbio Therapeutics Corp.